Föreläsning
Using Public-Private Partnerships for Discovery, Development and Delivery of Vaccines for Global Health
The International Vaccine Institute (IVI) welcomes scholars, experts and policymakers to participate in a scientific symposium. The event aims to explore how various financial support models and partnerships can help facilitate deployment of vaccines for the world’s most vulnerable populations. Professor Jan Holmgren of Gothenburg University, renowned for his groundbreaking research on cholera, is one of the keynote speakers at the event. See below the program and registration details.
Recent pandemic outbreaks have underscored the urgent need for enhanced global cooperation to tackle future threats and develop safer vaccines. With over 27 years of experience in building cooperation between public and private sectors, IVI has been instrumental in facilitating vaccine development and improving health access for vulnerable populations worldwide. In line with its commitment to strengthening international partnerships, IVI is opening its permanent office in Stockholm on 3rd of May 2024. To commemorate this milestone, IVI organizes a symposium aimed at fostering dialogue and collaboration in vaccine research and public health initiatives.
The symposium will offer an opportunity to learn from some prominent scholars in the field and IVI’s leadership about several examples of such cooperation that resulted in the successful deployment of vaccines and saving lives worldwide.
Jan Holmgren, senior professor of medical microbiology, renowned for his groundbreaking research on cholera, will share his insights of oral cholera vaccine development – from discovery to delivery in low- and middle-income countries.
Manki Song, Deputy Director General at IVI, will address the topic of vaccine self-sufficiency in Korea and the collaborative role played by IVI.
Dr. Anh Wartel, Director of the IVI Europe Regional Office, will offer her prospective on IVI’s mission and goals in Europe and discuss how IVI works using public-private partnerships.
The symposium will conclude with a panel discussion, focusing on current challenges of vaccine development for chikungunya, a viral disease that is causing large-scale outbreaks around the world. Among the participants in the panel discussion: Gerald McInerney, professor at Karolinska Institutet, Kwasi Amfo, representing Coalition for Epidemic Preparedness Innovations (CEPI) and Sushant Sahastrabuddhe, Associate Director General, IVI.